AssetMark Inc’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.52K Buy
47
+9
+24% +$900 ﹤0.01% 2596
2025
Q4
$3.7K Hold
38
﹤0.01% 2568
2025
Q3
$2.7K Hold
38
﹤0.01% 2551
2025
Q2
$2.27K Buy
38
+11
+41% +$603 ﹤0.01% 2390
2025
Q1
$1.42K Buy
+27
New +$1.52K ﹤0.01% 2241

Other funds holding IRMD

AssetMark Inc's IRMD Position: Q1 2026 in Review

AssetMark Inc increased its iRadimed (IRMD) stake by 24% in Q1 2026, buying an estimated $900 and bringing the position to 47 shares worth $4.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2596.

AssetMark Inc first reported a position in IRMD in Q1 2025 and has held it in 5 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • AssetMark Inc held 47 shares of iRadimed worth $4.52K as of Q1 2026.
  • AssetMark Inc bought 9 iRadimed shares in Q1 2026, an estimated $900.
  • iRadimed made up ﹤0.01% of AssetMark Inc's portfolio in Q1 2026, its #2596 holding.
  • AssetMark Inc first reported a position in iRadimed in Q1 2025 and has held it in 5 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on AssetMark Inc's 13F filing for Q1 2026, filed 6 May 2026.